The era of serum prostate specific antigen as a marker for biopsy of the prostate and detecting prostate cancer is now over in the USA
Open Access
- 10 November 2004
- journal article
- Published by Wiley in BJU International
- Vol. 94 (7) , 963-964
- https://doi.org/10.1111/j.1464-410x.2004.05212.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- PREOPERATIVE SERUM PROSTATE SPECIFIC ANTIGEN LEVELS BETWEEN 2 AND 22 NG./ML. CORRELATE POORLY WITH POST-RADICAL PROSTATECTOMY CANCER MORPHOLOGY: PROSTATE SPECIFIC ANTIGEN CURE RATES APPEAR CONSTANT BETWEEN 2 AND 9 NG./ML.Journal of Urology, 2002
- PROSTATE CANCER DIAGNOSIS USING A SATURATION NEEDLE BIOPSY TECHNIQUE AFTER PREVIOUS NEGATIVE SEXTANT BIOPSIESJournal of Urology, 2001
- SERUM PROSTATE SPECIFIC ANTIGEN IS A STRONG PREDICTOR OF FUTURE PROSTATE GROWTH IN MEN WITH BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 2000
- Biological Determinants of Cancer Progression in Men With Prostate CancerJAMA, 1999
- Age and Racial Distribution of Prostatic Intraepithelial NeoplasiaEuropean Urology, 1996
- Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radical Prostatectomy Treated PatientsJournal of Urology, 1989
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987